CD4 and lung carcinoma: As shown in graphs in Fig 3A, DC-based HHP lung cancer vaccine stimulated significantly higher number of IFN-γ-producing CD8+ and CD4+ T cells in comparison to iDC or DC pulsed with HHP-killed tumor cells alone.